The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil

Drug Development and Industrial Pharmacy

Volumn 38, Issue 12, 2012, Pages 1521-1529

  Yanyu, Xiao ^a   Fang, Liu ^a   Qineng, Ping ^a   Hao, Cai ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

5 fluorouracil; AOT; IPM; microemulsion; transdermal delivery; Tween 85

Indexed keywords

EMULSIFYING AGENT; FLUOROURACIL; MYRISTIC ACID ISOPROPYL ESTER; POLYSORBATE 85; UNCLASSIFIED DRUG; WATER;

AEROSOL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ELECTRIC CONDUCTIVITY; IN VITRO STUDY; MALE; MICROEMULSION; MOUSE; NONHUMAN; SKIN PERMEABILITY; SURFACE TENSION; VISCOSITY; WATER CONTENT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG DELIVERY SYSTEMS; EMULSIONS; FLUOROURACIL; MALE; MICE; MYRISTATES; PARTICLE SIZE; POLYSORBATES; SKIN ABSORPTION; SOLUBILITY; SURFACE-ACTIVE AGENTS; WATER;

EID: 84868346049     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.654795     Document Type: Article

References (35)

1. Morse LG, Kendrick C, Hooper D, Ward H, Parry E. (2003). Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil. Dermatol Surg, 29:1150-3; discussion 1153. (Pubitemid 37370451)
2. Nguyen TH, Ho DQ. (2002). Nonmelanoma skin cancer. Curr Treat Options Oncol, 3:193-203.
3. Gross K, Kircik L, Kricorian G. (2007). 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg, 33:433-9; discussion 440. (Pubitemid 46570116)
4. Lee WR, Shen SC, Wang KH, Hu CH, Fang JY. (2002). The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci, 91:1613-1626.
5. Fang JY, Hung CF, Fang YP, Chan TF. (2004). Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment. Int J Pharm, 270:241-249.
6. Patrick AI, Beall HD, Gilroy P, Sloan KB. (1997). Effect of vehicles on topical delivery of 5-fluorouracil (5-FU) by 1-acyl-5-FU prodrugs. Int J Pharm, 154:39-48. (Pubitemid 27326818)
7. Gao S, Singh J. (1998). Effect of oleic acid/ethanol and oleic acid/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis. Int J Pharm, 165:45-55. (Pubitemid 28218343)
8. Singh BN, Singh RB, Singh J. (2005). Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm, 298:98-107. (Pubitemid 40828331)
9. Donatella Paolino, Donato Cosco, Rita Muzzalupo, Elena Trapasso, Nevio Picci, Massimo Fresta. (2008). Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm, 353:233-242.
10. Raja M., Hanif, Ping Qineng, Gao Zhan. (1998). Penetration enhancing effect of tetrahydrogeraniol on the percutaneous absorption of 5-fluorouracil from gels in excised rat skin. J Control Release, 55:297-302. (Pubitemid 28477620)
11. Rhee YS, Choi JG, Park ES, Chi SC. (2001). Transdermal delivery of ketoprofen using microemulsions. Int J Pharm, 228:161-170.
12. Lee PJ, Langer R, Shastri VP. (2003). Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res, 20:264-269. (Pubitemid 36269734)
13. Anna Kogan, Nissim Garti. (2006). Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci, 123-126:369-385. (Pubitemid 44665819)
14. Kreilgaard M. (2002). Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev, 54 Suppl 1:S77-S98. (Pubitemid 35379956)
15. Zhang YT, Zhao JH, Zhang SJ, Zhong YZ, Wang Z, Liu Y et al. (2011). Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion. Int J Nanomedicine, 6:2469-2482.
16. Wu H, Ramachandran C, Weiner ND, Roessler BJ. (2001). Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int J Pharm, 220:63-75. (Pubitemid 32476842)
17. Varshney M, Khanna T, Changez M. (1999). Effects of AOT micellar systems on the transdermal permeation of glyceryl trinitrate. Colloids Surf B: Biointerfaces, 13:1-11. (Pubitemid 29080733)
18. Santus GC, Baker RW. (1993). Transdermal enhancer patent literature. J Control Release, 25:1-20. (Pubitemid 23168626)
19. Gupta RR, Jain SK, Varshney M. (2005). AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf B Biointerfaces, 41:25-32. (Pubitemid 40215481)
20. Paul BK, Mitra RK. (2005). Water solubilization capacity of mixed reverse micelles: effect of surfactant component, the nature of the oil, and electrolyte concentration. J Colloid Interface Sci, 288:261-279. (Pubitemid 40779522)
21. Liu H, Li S, Wang Y, Han F, Dong Y. (2006). Bicontinuous water-AOT/Tween85-isopropyl myristate microemulsion: a new vehicle for transdermal delivery of cyclosporin A. Drug Dev Ind Pharm, 32:549-557. (Pubitemid 43982405)
22. Liu H, Wang Y, Lang Y, Yao H, Dong Y, Li S. (2009). Bicontinuous cyclosporin a loaded water-AOT/Tween 85-isopropylmyristate microemulsion: structural characterization and dermal pharmacokinetics in vivo. J Pharm Sci, 98:1167-1176.
23. Liu F, Xiao YY, Ping QN, Yang C. (2009). Water in oil microemulsions for transdermal delivery of fluorouracil. Acta Pharm Sin, 44:540-547.
24. Dong X, Ke X, Liao Z. (2011). The microstructure characterization of meloxicam microemulsion and its influence on the solubilization capacity. Drug Dev Ind Pharm, 37:894-900.
25. El-Hadidy GN, Ibrahim HK, Mohamed MI, El-Milligi MF. (2011). Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm, 38:64-72.
26. Leser ME, Evert WC, Agterol WGM. (1996). Phase behaviour of lecithinwater-alcohol-triacylglycerol mixtures. Colloids Surf A, 116:293-308.
27. Mehta SK, Bala K. (2000). Tween-based microemulsions: a percolation view. Fluid Phase Equilibria, 172:197-209. (Pubitemid 32475905)
28. Brian A, Antony J, Williams. (1997). Microstructure analysis at the percolation threshold in reverse microemulsions. Colloids Surf A, 128:1-11. (Pubitemid 27359695)
29. Teng HN, Zhou XT. (2003). The properties of the microemulsions composed of non-ionic surfactant. J Qingdao University of Science and Technology, 24:196-199.
30. Gennes DPG. (1976). La percolation: un concept unificateur. Recherche, 72:919-927.
31. Laguës M, Ober R, Taupin C. (1978). Study of structure and electrical conductivity in microemulsions: evidence for percolation mechanism and phase inversion. J Phys Lett, 39:487-491.
32. Gradzielski M, Hoffman H. (1999). Rheological properties of microemulsions. In: Kumar P, Mittal KL, eds. Handbook of Microemulsion Science and Technology. New York: Marcel Dekker, Inc.
33. Note C, Koetz J, Kosmella S. (2006). Structural changes in poly(ethyleneimine) modified microemulsion. J Colloid Interface Sci, 302:662-668. (Pubitemid 44354883)
34. Fujieda T, Ohta K, Wakabayashi N, Higuchi S. (1997). H-aggregation of methyl orange at the interface between the water phase and oil phase in a water-in-oil microemulsion. J Colloid Interface Sci, 185:332-334. (Pubitemid 27466782)
35. Osborne DW, Ward AJ, O'Neill KJ. (1991). Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol, 43:450-454.